Skip to main content
Erschienen in: World Journal of Urology 5/2013

01.10.2013 | Topic paper

Adrenal tumours are more predominant in females regardless of their histological subtype: a review

verfasst von: François Audenet, Arnaud Méjean, Emmanuel Chartier-Kastler, Morgan Rouprêt

Erschienen in: World Journal of Urology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Adrenal tumours are a heterogeneous group of rare tumours. The aim of this article was to critically review gender-specific differences in the incidence, prognosis and symptoms of the different subtypes of adrenal tumours.

Methods

Data acquisition regarding gender differences in adrenal tumours was performed using MEDLINE searches with combinations of the following keywords: adrenal tumours, gender, sex differences, adrenocortical carcinoma, pheochromocytoma, incidentaloma, risk factors and genetic aspects.

Results

Data are scarce in the literature concerning the effects of gender on adrenal lesions. Although the incidence of most types of tumours (other than breast cancer and other gender-related tumours) is higher in men than in women, evidence suggests that adrenal tumours (i.e. incidentalomas, adrenal carcinomas, oncocytomas and adrenal cysts) are more frequent in women than in men. In addition, female patients have significantly increased numbers of self-reported signs and symptoms of pheochromocytoma than male patients, irrespective of biochemical phenotype and tumour presentation. Relatively little research has been performed examining the reasons for these disparities. However, hormonal interactions involving complex adrenal, endocrine and neurocrine functions together with variations in hormonal receptor sensitivity have been hypothesised to be involved.

Conclusion

Gender differences exist in the incidence and symptoms of several subtypes of adrenal tumours. The reasons for these disparities are not well established. In addition to epidemiological data, these results need to be further investigated to better understand the role of genetic and hormonal predispositions in the development, behaviour and aggressiveness of adrenal tumours.
Literatur
1.
Zurück zum Zitat Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M et al (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667–680. doi:10.1677/erc.1.01029 PubMedCrossRef Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M et al (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667–680. doi:10.​1677/​erc.​1.​01029 PubMedCrossRef
2.
Zurück zum Zitat Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340PubMedCrossRef Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340PubMedCrossRef
4.
Zurück zum Zitat Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236. doi:10.3322/caac.20121 PubMedCrossRef Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236. doi:10.​3322/​caac.​20121 PubMedCrossRef
6.
Zurück zum Zitat Higdon JV, Frei B (2005) Is there a gender difference in the effect of antioxidants on cancer risk? Br J Nutr 94:139–140PubMedCrossRef Higdon JV, Frei B (2005) Is there a gender difference in the effect of antioxidants on cancer risk? Br J Nutr 94:139–140PubMedCrossRef
7.
9.
Zurück zum Zitat Young WF Jr (2000) Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185PubMedCrossRef Young WF Jr (2000) Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185PubMedCrossRef
10.
Zurück zum Zitat Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273–285PubMedCrossRef Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273–285PubMedCrossRef
11.
Zurück zum Zitat Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macri C et al (1998) Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 83:55–62PubMedCrossRef Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macri C et al (1998) Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 83:55–62PubMedCrossRef
12.
Zurück zum Zitat Bravo EL, Tagle R (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24:539–553PubMedCrossRef Bravo EL, Tagle R (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24:539–553PubMedCrossRef
13.
Zurück zum Zitat Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P et al (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427–1434PubMedCrossRef Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P et al (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427–1434PubMedCrossRef
14.
Zurück zum Zitat Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637–644PubMedCrossRef Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637–644PubMedCrossRef
15.
Zurück zum Zitat Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM et al (2005) Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51:735–744. doi:10.1373/clinchem.2004.045484 PubMedCrossRef Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM et al (2005) Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51:735–744. doi:10.​1373/​clinchem.​2004.​045484 PubMedCrossRef
16.
Zurück zum Zitat Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM (2000) Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36:1233–1238PubMedCrossRef Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM (2000) Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36:1233–1238PubMedCrossRef
17.
Zurück zum Zitat Luzier AB, Nawarskas JJ, Anonuevo J, Wilson MF, Kazierad DJ (1998) The effects of gender on adrenergic receptor responsiveness. J Clin Pharmacol 38:618–624PubMedCrossRef Luzier AB, Nawarskas JJ, Anonuevo J, Wilson MF, Kazierad DJ (1998) The effects of gender on adrenergic receptor responsiveness. J Clin Pharmacol 38:618–624PubMedCrossRef
18.
Zurück zum Zitat Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE (2008) Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med 5:22–29. doi:10.1038/ncpcardio1066 PubMedCrossRef Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE (2008) Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med 5:22–29. doi:10.​1038/​ncpcardio1066 PubMedCrossRef
20.
Zurück zum Zitat Kloos RT, Gross MD, Shapiro B, Francis IR, Korobkin M, Thompson NW (1997) Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I–6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 21:36–40PubMedCrossRef Kloos RT, Gross MD, Shapiro B, Francis IR, Korobkin M, Thompson NW (1997) Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I–6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 21:36–40PubMedCrossRef
23.
Zurück zum Zitat Tauchmanova L, Colao A, Marzano LA, Sparano L, Camera L, Rossi A et al (2004) Andrenocortical carcinomas: twelve-year prospective experience. World J Surg 28:896–903PubMedCrossRef Tauchmanova L, Colao A, Marzano LA, Sparano L, Camera L, Rossi A et al (2004) Andrenocortical carcinomas: twelve-year prospective experience. World J Surg 28:896–903PubMedCrossRef
25.
Zurück zum Zitat Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72:3145–3155PubMedCrossRef Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72:3145–3155PubMedCrossRef
27.
Zurück zum Zitat Strickland JE, Saviolakis GA, Weislow OS, Allen PT, Hellman A, Fowler AK (1980) Spontaneous adrenal tumors in the aged, ovariectomized NIH swiss mouse without enhanced retrovirus expression. Cancer Res 40:3570–3575PubMed Strickland JE, Saviolakis GA, Weislow OS, Allen PT, Hellman A, Fowler AK (1980) Spontaneous adrenal tumors in the aged, ovariectomized NIH swiss mouse without enhanced retrovirus expression. Cancer Res 40:3570–3575PubMed
28.
Zurück zum Zitat Noble RL, Hochachka BC, King D (1975) Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res 35:766–780PubMed Noble RL, Hochachka BC, King D (1975) Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res 35:766–780PubMed
29.
Zurück zum Zitat Rahman NA, Kiiveri S, Siltanen S, Levallet J, Kero J, Lensu T et al (2001) Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61. Reprod Biol 1:5–9PubMed Rahman NA, Kiiveri S, Siltanen S, Levallet J, Kero J, Lensu T et al (2001) Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61. Reprod Biol 1:5–9PubMed
30.
Zurück zum Zitat Vuorenoja S, Rivero-Muller A, Kiiveri S, Bielinska M, Heikinheimo M, Wilson DB et al (2007) Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6. Mol Cell Endocrinol 269:38–45. doi:10.1016/j.mce.2006.11.013 PubMedCrossRef Vuorenoja S, Rivero-Muller A, Kiiveri S, Bielinska M, Heikinheimo M, Wilson DB et al (2007) Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6. Mol Cell Endocrinol 269:38–45. doi:10.​1016/​j.​mce.​2006.​11.​013 PubMedCrossRef
31.
Zurück zum Zitat Liou LS, Kay R (2000) Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am 27:403–421PubMedCrossRef Liou LS, Kay R (2000) Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am 27:403–421PubMedCrossRef
32.
Zurück zum Zitat Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Menegaux F et al (2011) Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d’etude des Tumeurs Endocrines. Eur J Endocrinol 165:97–105. doi:10.1530/EJE-10-0950 PubMedCrossRef Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Menegaux F et al (2011) Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d’etude des Tumeurs Endocrines. Eur J Endocrinol 165:97–105. doi:10.​1530/​EJE-10-0950 PubMedCrossRef
33.
Zurück zum Zitat Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G et al (2004) Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 12:231–243PubMedCrossRef Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G et al (2004) Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 12:231–243PubMedCrossRef
34.
Zurück zum Zitat Akatsu T, Kameyama K, Araki K, Ashizawa T, Wakabayashi G, Kitajima M (2008) Functioning adrenocortical oncocytoma: the first documented case producing interleukin-6 and review of the literature. J Endocrinol Invest 31:68–73PubMed Akatsu T, Kameyama K, Araki K, Ashizawa T, Wakabayashi G, Kitajima M (2008) Functioning adrenocortical oncocytoma: the first documented case producing interleukin-6 and review of the literature. J Endocrinol Invest 31:68–73PubMed
36.
Zurück zum Zitat Olsson CA, Krane RJ, Klugo RC, Selikowitz SM (1973) Adrenal myelolipoma. Surgery 73:665–670PubMed Olsson CA, Krane RJ, Klugo RC, Selikowitz SM (1973) Adrenal myelolipoma. Surgery 73:665–670PubMed
37.
Zurück zum Zitat Patel VG, Babalola OA, Fortson JK, Weaver WL (2006) Adrenal myelolipoma: report of a case and review of the literature. Am Surg 72:649–654PubMed Patel VG, Babalola OA, Fortson JK, Weaver WL (2006) Adrenal myelolipoma: report of a case and review of the literature. Am Surg 72:649–654PubMed
38.
Zurück zum Zitat Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163–1168. doi:10.2214/AJR.07.2799 PubMedCrossRef Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163–1168. doi:10.​2214/​AJR.​07.​2799 PubMedCrossRef
Metadaten
Titel
Adrenal tumours are more predominant in females regardless of their histological subtype: a review
verfasst von
François Audenet
Arnaud Méjean
Emmanuel Chartier-Kastler
Morgan Rouprêt
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-1011-1

Weitere Artikel der Ausgabe 5/2013

World Journal of Urology 5/2013 Zur Ausgabe

Schützt auch die medikamentöse Gewichtsreduktion vor Krebs?

03.06.2024 ASCO 2024 Kongressbericht

Offenbar muss es nicht immer die bariatrische Chirurgie sein, wenn es darum geht, durch deutlichen Gewichtsverlust auch das Krebsrisiko günstig zu beeinflussen. Eine große Kohortenanalyse zur Behandlung mit GLP-1-Agonisten wurde dazu auf der ASCO-Tagung vorgestellt.

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.